Bilaketaren emaitzak - Janku, Filip

Bringing target-matched PI3King from the bench to the clinic nork Janku, Filip

Testu osoa Testu osoa Testu osoa

Tumor heterogeneity in the clinic: is it a real problem? nork Janku, Filip

Testu osoa Testu osoa Testu osoa

Deciding site of biopsy at metastatic relapse: reply nork Janku, Filip

Testu osoa Testu osoa Testu osoa

Liquid Biopsies Using Plasma Exosomal Nucleic Acids nork Möhrmann, Lino, Janku, Filip

Testu osoa Testu osoa Testu osoa

Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives nork Bupathi, Manojkumar, Kaseb, Ahmed, Janku, Filip

Testu osoa Testu osoa Testu osoa

Targeted Therapies for Advanced Ewing Sarcoma Family of Tumours nork Jiang, Yunyun, Ludwig, Joseph, Janku, Filip

Testu osoa Testu osoa Testu osoa

Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet? nork Polivka, Jiri, Pesta, Martin, Janku, Filip

Testu osoa Testu osoa Testu osoa

Successful Treatment of Castleman’s Disease with Interleukin-1 Receptor Antagonist (Anakinra) nork El-Osta, Hazem, Janku, Filip, Kurzrock, Razelle

Testu osoa Testu osoa Testu osoa

Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening nork Adashek, Jacob J., Janku, Filip, Kurzrock, Razelle

Testu osoa Testu osoa Testu osoa

A Tale of Two Histiocytic Disorders nork Janku, Filip, Munoz, Javier, Subbiah, Vivek, Kurzrock, Razelle

Testu osoa Testu osoa Testu osoa

Castleman’s disease and sarcoidosis, a rare association resulting in a “mixed” response: a case report nork Mohammed, Anwarullah, Janku, Filip, Qi, Ming, Kurzrock, Razelle

Testu osoa Testu osoa Testu osoa

A kinase-independent biological activity for insulin growth factor-1 receptor (IGF-1R): Implications for Inhibition of the IGF-1R signal nork Janku, Filip, Huang, Helen J., Angelo, Laura S., Kurzrock, Razelle

Testu osoa Testu osoa

Bevacizumab-Based Treatment in Colorectal Cancer with a NRAS Q61K Mutation nork Janku, Filip, Wheler, Jennifer J., Hong, David S., Kurzrock, Razelle

Testu osoa Testu osoa Testu osoa

STAT3 Inhibitors: Finding a Home in Lymphoma and Leukemia nork Munoz, Javier, Dhillon, Navjot, Janku, Filip, Watowich, Stephanie S., Hong, David S.

Testu osoa Testu osoa Testu osoa

Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing nork Janku, Filip, Kaseb, Ahmed O., Tsimberidou, Apostolia M., Wolff, Robert A., Kurzrock, Razelle

Testu osoa Testu osoa

Non-Small Cell Lung Cancer with HER2 Exon 20 Mutation: Regression with Dual HER2 Inhibition and Anti-VEGF Combination Treatment nork Falchook, Gerald S., Janku, Filip, Tsao, Anne S., Bastida, Christel C., Stewart, David J., Kurzrock, Razelle

Testu osoa Testu osoa Testu osoa

Next generation sequencing of carcinoma of unknown primary reveals novel combinatorial strategies in a heterogeneous mutational landscape nork Subbiah, Ishwaria M., Tsimberidou, Apostolia, Subbiah, Vivek, Janku, Filip, Roy-Chowdhuri, Sinchita, Hong, David S.

Testu osoa Testu osoa Testu osoa

A novel immunomodulatory and molecularly targeted strategy for refractory Hodgkin's lymphoma nork Subbiah, Vivek, Brown, Robert E., McGuire, Mary F., Buryanek, Jamie, Janku, Filip, Younes, Anas, Hong, David

Testu osoa Testu osoa

Multiple gene aberrations and breast cancer: lessons from super-responders nork Wheler, Jennifer J., Atkins, Johnique T., Janku, Filip, Moulder, Stacy L., Yelensky, Roman, Stephens, Philip J., Kurzrock, Razelle

Testu osoa Testu osoa Testu osoa

Challenges and perspective of drug repurposing strategies in early phase clinical trials nork Kato, Shumei, Moulder, Stacy L., Ueno, Naoto T., Wheler, Jennifer J., Meric-Bernstam, Funda, Kurzrock, Razelle, Janku, Filip

Testu osoa Testu osoa